BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17578758)

  • 1. Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.
    Kino T
    Horm Metab Res; 2007 Jun; 39(6):420-4. PubMed ID: 17578758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress.
    Kino T; Ichijo T; Amin ND; Kesavapany S; Wang Y; Kim N; Rao S; Player A; Zheng YL; Garabedian MJ; Kawasaki E; Pant HC; Chrousos GP
    Mol Endocrinol; 2007 Jul; 21(7):1552-68. PubMed ID: 17440046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic.
    Chrousos GP; Kino T
    Sci STKE; 2005 Oct; 2005(304):pe48. PubMed ID: 16204701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue glucocorticoid resistance/hypersensitivity syndromes.
    Kino T; De Martino MU; Charmandari E; Mirani M; Chrousos GP
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):457-67. PubMed ID: 12943736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.
    Chrousos GP; Kino T
    Ann N Y Acad Sci; 2009 Oct; 1179():153-66. PubMed ID: 19906238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids.
    Bamberger CM; Schulte HM; Chrousos GP
    Endocr Rev; 1996 Jun; 17(3):245-61. PubMed ID: 8771358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
    Charmandari E; Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of glucocorticoids: beyond receptors.
    van der Laan S; Meijer OC
    Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid action networks and complex psychiatric and/or somatic disorders.
    Chrousos GP; Kino T
    Stress; 2007 Jun; 10(2):213-9. PubMed ID: 17514590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes.
    Nicolaides NC; Charmandari E
    Hormones (Athens); 2017 Apr; 16(2):124-138. PubMed ID: 28742501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between the glucocorticoid receptor and MyoD family inhibitor domain-containing protein provides a new mechanism for generating tissue-specific responses to glucocorticoids.
    Oakley RH; Busillo JM; Cidlowski JA
    J Biol Chem; 2017 Apr; 292(14):5825-5844. PubMed ID: 28223352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.
    De Martino MU; Alesci S; Chrousos GP; Kino T
    Ann N Y Acad Sci; 2004 Jun; 1024():72-85. PubMed ID: 15265774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of action of glucocorticoids].
    Dejean C; Richard D
    Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid resistant syndromes--molecular basis and clinical presentations.
    Brönnegård M; Stierna P; Marcus C
    J Neuroendocrinol; 1996 Jun; 8(6):405-15. PubMed ID: 8809670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary generalized glucocorticoid resistance and hypersensitivity.
    Charmandari E
    Horm Res Paediatr; 2011; 76(3):145-55. PubMed ID: 21912096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions between the glucocorticoid receptor and transcription factors].
    Gouilleux F
    J Soc Biol; 1999; 193(4-5):369-73. PubMed ID: 10689619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
    Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.